Share This Author
The rise in spending among Medicare beneficiaries: the role of chronic disease prevalence and changes in treatment intensity.
Using the metabolic syndrome as a case study, it is found that the share of patients treated with medications has increased 11.5 percentage points in less than ten years, raising important questions about the "fit" of how Medicare pays for services for complex medical management.
The rise in health care spending and what to do about it.
- K. Thorpe
- Medicine, Political ScienceHealth affairs
- 1 November 2005
To be effective, reforms should focus on health promotion, public health interventions, and the cost-effective use of medical care.
A study of medical injury and medical malpractice.
For nearly two decades, an atmosphere of crisis has enveloped the authors' system of medical-malpractice litigation and liability insurance, and legislators have responded to the problems of a shrinking insurance market and rising insurance costs by restricting liability and, in some cases, limiting damages.
The medical malpractice 'crisis': recent trends and the impact of state tort reforms.
- K. Thorpe
- MedicineHealth affairs
- 21 January 2004
This analysis finds that premiums in states that cap awards are 17.1 percent lower than inStates that don't cap, and whether these stopgap solutions promote the goals of the U.S. liability system is at issue.
Hospital characteristics associated with adverse events and substandard care.
It is suggested that certain types of hospitals have significantly higher rates of injuries due to substandard care and that some hospitals' populations may be at risk of suffering a poor outcome.
The impact of obesity on rising medical spending.
This work estimates obesity-attributable health care spending increases between 1987 and 2001 and estimates that increases in obesity prevalence alone account for 12 percent of the growth in health spending.
Chronic conditions account for rise in Medicare spending from 1987 to 2006.
Health reform must address changed health needs through evidence-based community prevention, care coordination, and support for patient self-management.
Differences in disease prevalence as a source of the U.S.-European health care spending gap.
Differences in disease prevalence and treatment rates for ten of the most costly conditions between the United States and ten European countries are examined using surveys of the noninstitutionalized population age fifty and older.
Colorectal cancer screening, 1997-1999: role of income, insurance and policy.